PTC Therapeutics, Inc. Goes on Another Biotech Roller Coaster Ride | Tackle Trading: The #1 rated trading education platform

PTC Therapeutics, Inc. Goes on Another Biotech Roller Coaster Ride

There are certainly some roller coaster rides you can go on if you trade biotech or pharmaceutical stocks. In addition to the unknown and known events that every company has, there are constantly (at least it seems that way) news related to the company’s development of drugs and therapeutics that dramatically impact the stock. That was the case the other day for PTC Therapeutics, Inc. (PTCT) which closed down more than 19% after disappointing phase 3 trial results on nonsense mutation cystic fibrosis treatment candidate.

Share this

X
Facebook
LinkedIn
Reddit
Pinterest
Telegram
WhatsApp

More Insights

Join the #1 Rated Trading Education Platform

Learn to generate monthly cash flow from the financial markets and how to grow long-term lasting wealth. Tackle Trading is an amazing online community for active traders that is led by seasoned market professionals. Tap into the power of Tackle Trading’s proven trading system and learn how easy it is to make money with the proper coaching and education.

8,800+

Members

100+

Reviews

Ready to take your trading to the next level?

Get in touch today and receive a FREE complimentary consultation.

Let us help you start trading!

Our Pro Membership gives you the tools to tackle all your trading obstacles.

Register for the Master Trader Live Workshop and get the First 15 Days on Us

ELEVATE YOUR TRADING SKILLS

Master Income Strategies

Unlock the Secrets to Income with Covered Calls

Holiday Sales

Up to
43%
OFF

Days
Hours
Minutes
Seconds
Unfortunately, this offer is now closed. If you still want to take advantage of it, reach out to us at team@tackletrading.com.